相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
X. Yuan et al.
ONCOGENE (2014)
New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
Kuo-Pao Lai et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Castration-resistant Prostate Cancer: Novel Therapeutics Pre-or Post-Taxane Administration
Masaki Shiota et al.
CURRENT CANCER DRUG TARGETS (2013)
Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis
Tzu-Hua Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
T-H Lin et al.
CELL DEATH & DISEASE (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
Overcoming mutation-based resistance to antiandrogens with rational drug design
Minna D. Balbas et al.
ELIFE (2013)
Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer
Yekaterina Y. Zaytseva et al.
CANCER RESEARCH (2012)
Lipid metabolism in cancer
Claudio R. Santos et al.
FEBS JOURNAL (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
Charles J. Ryan et al.
CLINICAL CANCER RESEARCH (2011)
The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction
Jinrong Cheng et al.
CANCER BIOLOGY & THERAPY (2010)
Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice
Soichiro Murata et al.
CANCER SCIENCE (2010)
Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
Y. Niu et al.
ONCOGENE (2010)
Androgen Receptor Promotes Hepatitis B Virus-Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
Ming-Heng Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
Kamilla Malinowska et al.
ENDOCRINE-RELATED CANCER (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Ligand-independent activation of the androgen receptor by insulin-like growth factor-i and the role of the MAPK pathway in skeletal muscle cells
Hye Jin Kim et al.
MOLECULES AND CELLS (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A. Vazquez-Martin et al.
CELL PROLIFERATION (2008)
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma
Cheng-Lung Ma et al.
GASTROENTEROLOGY (2008)
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
Michelangelo Fiorentino et al.
LABORATORY INVESTIGATION (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer
Elahe A. Mostaghel et al.
CANCER RESEARCH (2007)
Promotion of bladder cancer development and progression by androgen receptor signals
Hiroshi Miyamoto et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Zhiming Yang et al.
NATURE MEDICINE (2007)
Androgen activation of the sterol regulatory element-binding protein pathway: Current insights
Hannelore V. Heemers et al.
MOLECULAR ENDOCRINOLOGY (2006)
Fatty acid synthase and cancer: New application of an old pathway
FP Kuhajda
CANCER RESEARCH (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence
SL Ettinger et al.
CANCER RESEARCH (2004)
Androgen deprivation therapy for prostate cancer: Current status and future prospects
H Miyamoto et al.
PROSTATE (2004)
Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines
F Orio et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression
ES Pizer et al.
PROSTATE (2001)
分享论文
